Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025

SELL
$73.86 - $108.74 $295 - $434
-4 Reduced 0.14%
2,932 $240 Million
Q4 2024

Jan 22, 2025

BUY
$76.22 - $116.71 $914 - $1,400
12 Added 0.41%
2,936 $263 Million
Q3 2024

Oct 23, 2024

SELL
$77.7 - $123.62 $12,742 - $20,273
-164 Reduced 5.31%
2,924 $321 Million
Q2 2024

Aug 06, 2024

BUY
$58.87 - $83.05 $181,790 - $256,458
3,088 New
3,088 $248 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $3.64B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.